newsfilter
← Latest News
GlobeNewswire·

Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series

SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. ("Biomea") (NASDAQ:BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in Citi's SMID Biotech C-Suite